Target intelligence / Profile preview

UDP glucuronosyltransferase family 2 member B24, pseudogene (UGT2B24P)

Target: UGT2B24P

Overview

UDP glucuronosyltransferase family 2 member B24, pseudogene (UGT2B24P) is classified as a pseudogene, meaning it is a non-functional segment of DNA resembling a gene but lacking the ability to code for a functional protein product[2]. As a pseudogene, UGT2B24P does not encode an active receptor, enzyme, transporter, or other therapeutic target, and is not known to play a role in human disease or drug interaction. Most genomic and functional databases list no roles, aliases, or associated pathologies for this locus. The functional UDP-glucuronosyltransferase (UGT) family enzymes are important in metabolism and detoxification, but UGT2B24P itself is non-coding and not pharmacologically relevant[2].

Beyond the preview

Go deeper on UDP glucuronosyltransferase family 2 member B24, pseudogene (UGT2B24P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on UDP glucuronosyltransferase family 2 member B24, pseudogene (UGT2B24P).

Explore the full profile